Peter Rahmer - Mar 27, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Corporate Development Officer
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Mar 27, 2025
Transactions value $
-$701
Form type
4
Date filed
3/31/2025, 04:15 PM
Previous filing
Jan 30, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$701 -247 -0.06% $2.84 402K Mar 27, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 252,612 shares underlying RSUs.

Remarks:

Chief Corporate Development Officer